Sanam Loghavi: Among the most aggressive forms of AML
Sanam Loghavi shared a post on X:
“*Left: acute erythroid leukemia (formerly pure erythroid leukemia) nearly always shows bi-allelic loss of TP53
*Right: acute megakaryoblastic leukemia, variable genetics.
Among the most aggressive forms of AML
*Both resistant to venetoclax”
Source: Sanam Loghavi/X
Sanam Loghavi is an Associate Professor of Pathology and Laboratory Medicine at the Department of Hematopathology at MD Anderson Cancer Center. She is the Medical Director of the ECOG/ACRIN Leukemia Bank at the Central Biorepository and Pathology Facility at MD Anderson.
She has authored around 200 peer-reviewed publications focused on hematologic neoplasms and is a co-investigator on several national and internationally-run clinical trials for hematologic malignancies. She serves on various committees including the HPATH Committee of the College of American Pathologists and the Education and Outreach Committees for International Clinical Cytometry Society.